Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole

被引：0
|
作者：
deJong, PC
vandeVen, J
Nortier, JWR
MaitimuSmeele, I
Donker, GH
Thijssen, JHH
Slee, PHTJ
Blankenstein, MA
机构：
[1] UNIV UTRECHT HOSP,DEPT INTERNAL MED,UTRECHT,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT ENDOCRINOL,UTRECHT,NETHERLANDS
[3] HOSP DIAKONESSENHUIS,DEPT INTERNAL MED,UTRECHT,NETHERLANDS
[4] ST ANTONIUS HOSP,DEPT INTERNAL MED,NIEUWEGEIN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer
    Chow, W. C. L.
    Yip, Y. S. A.
    Lam, C. K.
    Toi, M.
    [J]. BREAST, 2007, 16 : S50 - S50
  • [32] Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer
    Chow, Louis Wing-Cheong
    Yip, Adrian Yun-San
    Loo, Wings Tjing-Yung
    Toi, Masakazu
    [J]. CANCER LETTERS, 2008, 262 (02) : 232 - 238
  • [33] Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer
    Chow, Louis W.
    Yip, Adrian Y.
    Toi, Masakazu
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 140 - 140
  • [34] Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
    Makhlin, Igor
    McAndrew, Nicholas P.
    Wileyto, E. Paul
    Clark, Amy S.
    Holmes, Robin
    Bottalico, Lisa N.
    Mesaros, Clementina
    Blair, Ian A.
    Jeschke, Grace R.
    Fox, Kevin R.
    Domchek, Susan M.
    Matro, Jennifer M.
    Bradbury, Angela R.
    Feldman, Michael D.
    Hexner, Elizabeth O.
    Bromberg, Jacqueline F.
    DeMichele, Angela
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [35] EFFECTS OF AN IV AROMATASE INHIBITOR ON SERUM ESTROGEN CONCENTRATIONS IN NORMAL MALES
    CRAMER, MB
    HECK, K
    TAYLOR, CH
    JOHNSTON, JO
    MCLEES, BD
    LONGCOPE, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 148 - 148
  • [36] Peptide inhibition of cytokine-stimulated aromatase activity in breast tissue fibroblasts
    Parish, D
    Purohit, A
    Singh, A
    Rosankiewicz, J
    Ghilchik, MW
    Reed, MJ
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5): : 165 - 172
  • [37] The potential for aromatase inhibition in breast cancer prevention
    Lonning, PE
    Kragh, LE
    Erikstein, B
    Hagen, A
    Risberg, T
    Schlichting, E
    Geisler, J
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4423S - 4428S
  • [38] Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
    Igor Makhlin
    Nicholas P. McAndrew
    E. Paul Wileyto
    Amy S. Clark
    Robin Holmes
    Lisa N. Bottalico
    Clementina Mesaros
    Ian A. Blair
    Grace R. Jeschke
    Kevin R. Fox
    Susan M. Domchek
    Jennifer M. Matro
    Angela R. Bradbury
    Michael D. Feldman
    Elizabeth O. Hexner
    Jacqueline F. Bromberg
    Angela DeMichele
    [J]. npj Breast Cancer, 8
  • [39] Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression
    Lonning, Per E.
    Geisler, Jurgen
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2008, 108 (3-5): : 196 - 202
  • [40] Regulation of Aromatase Expression in Breast Cancer Tissue
    Bulun, S. E.
    Lin, Z.
    Zhao, H.
    Lu, M.
    Amin, S.
    Reierstad, S.
    Chen, D.
    [J]. STEROID ENZYMES AND CANCER, 2009, 1155 : 121 - 131
12345